Nicholas Denny

Nicholas Denny

Auto-generated profile, based on publicly available information

Nicholas Denny

MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2022 in Nature Genetics
Verified
Journal Article
Open access
PDF file
PRPauline Robbe
Pauline Robbe
KRKate E. Ridout
Kate E. Ridout
DVDimitrios V. Vavoulis
Dimitrios V. Vavoulis
HDHelene Dréau
Helene Dréau
BKBen Kinnersley
Ben Kinnersley
ASAnna Schuh
Anna Schuh
The value of genome-wide over targeted driver analyses for predicting clinical outcomes of cancer patients is debated. Here, we report the whole-genome sequencing of 485 chronic lymphocytic leukemia patients enrolled in clinical trials as part of the United Kingdom’s 100,000 Genomes Project. We identify an extended catalog of recurrent coding and noncoding genetic mutations that represents a source for future studies and provide the most complete high-resolution map of structural variants, copy number changes and global genome features including telomere length, mutational signatures and genomic complexity. We demonstrate the relationship of these features with clinical outcome and show that integration of 186 distinct recurrent genomic alterations defines five genomic subgroups that associate with response to therapy, refining conventional outcome prediction. While requiring independent validation, our findings highlight the potential of whole-genome sequencing to inform future risk stratification in chronic lymphocytic leukemia.

29 March 2023 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
JHJoseph C. Hamley
Joseph C. Hamley
HLHangpeng Li
Hangpeng Li
NDNicholas Denny
Nicholas Denny
DDDamien Downes
Damien Downes
JDJames O. J. Davies
James O. J. Davies

19 April 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
MBMohsin Badat
Mohsin Badat
AEAyesha Ejaz
Ayesha Ejaz
PHPeng Hua
Peng Hua
SRSiobhan Rice
Siobhan Rice
WZWeijiao Zhang
Weijiao Zhang
JDJames O. J. Davies
James O. J. Davies
Haemoglobin E (HbE) β-thalassaemia causes approximately 50% of all severe thalassaemia worldwide; equating to around 30,000 births per year. HbE β-thalassaemia is due to a point mutation in codon 26 of the human HBB gene on one allele (GAG; glutamatic acid → AAG; lysine, E26K), and any mutation causing severe β-thalassaemia on the other. When inherited together in compound heterozygosity these mutations can cause a severe thalassaemic phenotype. However, if only one allele is mutated individuals are carriers for the respective mutation and have an asymptomatic phenotype (β-thalassaemia trait). Here we describe a base editing strategy which corrects the HbE mutation either to wildtype (WT) or a normal variant haemoglobin (E26G) known as Hb Aubenas and thereby recreates the asymptomatic trait phenotype. We have achieved editing efficiencies in excess of 90% in primary human CD34 + cells. We demonstrate editing of long-term repopulating haematopoietic stem cells (LT-HSCs) using serial xenotransplantation in NSG mice. We have profiled the off-target effects using a combination of circularization for in vitro reporting of cleavage effects by sequencing (CIRCLE-seq) and deep targeted capture and have developed machine-learning based methods to predict functional effects of candidate off-target mutations.

8 November 2018 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
NDNicholas D. R. Denny
Nicholas D. R. Denny
LKLynne Keighley
Lynne Keighley
ZSZubin Siganporia
Zubin Siganporia
JTJecko Thachil
Jecko Thachil
MNMichael J. Nash
Michael J. Nash

29 November 2016 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
NDNicholas Denny
Nicholas Denny
SRSarika Raghunath
Sarika Raghunath
PBPraveen Bhatia
Praveen Bhatia
MAMuntasir Abdelaziz
Muntasir Abdelaziz
A 55-year-old Indian man presented with productive cough and a large left pleural effusion. Pleural fluid culture grew Mycobacterium tuberculosis, and he was started on antituberculosis therapy. One week later, the patient presented to hospital with drowsiness, dehydration and hypotension. He was transferred to critical care and only improved after starting hydrocortisone and stopping rifampicin. His short synACTHen test subsequently confirmed primary adrenal insufficiency, and a CT of the abdomen showed bilateral adrenal enlargement. Rifampicin is known to accelerate cortisol metabolism. We report the rare case of a rifampicin-induced adrenal crisis as a first presentation of Addison's disease in a patient with tuberculous infiltration of the adrenal glands.

21 September 2017 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
NDNicholas Denny
Nicholas Denny
UMUsman Maqsood
Usman Maqsood
SFStephen Fowler
Stephen Fowler
MMMohammed Munavvar
Mohammed Munavvar
Tracheobronchial foreign body (TFB) aspiration is a common occurrence in children compared with adults. Long-standing cases of TFB aspiration during childhood presenting in an adult have rarely been reported. We report the unique case of an endobronchial Playmobil traffic cone that went undetected for 40 years and presented as a suspected bronchogenic carcinoma. This was subsequently removed successfully with flexible bronchoscopy. To our knowledge this is the first case of a TFB that was overlooked this length of time.